Literature DB >> 23250478

Pars plana vitrectomy for disturbing primary vitreous floaters: clinical outcome and patient satisfaction.

Karlijn F de Nie1, N Crama, Maurits A D Tilanus, B Jeroen Klevering, Camiel J F Boon.   

Abstract

BACKGROUND: Primary vitreous floaters can be highly bothersome in some patients. In the case of persistently bothersome floaters, pars plana vitrectomy may be the most effective treatment. The aim of this study is to evaluate the incidence of complications, and patient satisfaction, after pars plana vitrectomy for disabling primary vitreous opacities.
METHODS: We included a total of 110 eyes that underwent pars plana vitrectomy between February 1998 and August 2010. Fifty-seven eyes (51.8%) underwent 20-gauge vitrectomy, whereas 53 eyes (48.2%) underwent 23-gauge vitrectomy. In a retrospective manner, we assessed intraoperative and postoperative complications. There was a considerable range of time between surgery and questionnaire (range: 4-136 months). Patient satisfaction was assessed by a questionnaire based on a modified NEI VFQ-25 questionnaire.
RESULTS: A retinal detachment occurred in 10.9% of cases, and the incidence did not differ significantly between the 20-gauge and 23-gauge vitrectomy groups. In 4.5% of the eyes, a retinal detachment developed within the first 3 months, and 6.4% occurred later in the postoperative period. Cystoid macular edema occurred in 5.5%, and an epiretinal membrane was seen postoperatively in 3.6% of cases. Development of glaucoma requiring glaucoma surgery, a macular hole, and postoperative scotoma, each occurred in 0.9% of cases. No cases of endophthalmitis occurred. Eighty-five percent of patients were satisfied or very satisfied with the results of the vitrectomy. Eighty-four percent of all patients were completely cured from their troublesome vitreous floaters, and an additional 9.3% of patients were less troubled by vitreous floaters. Ten patients (9.3%) were dissatisfied, and six of these patients (5.6%) had a serious complication that resulted in permanent visual loss.
CONCLUSIONS: Pars plana vitrectomy is an effective approach to treat primary vitreous floaters, resulting in a high rate of patient satisfaction. Postoperative complications may be more frequent than previously reported, so patients should be well-informed about the complication rate before reaching informed consent about this surgical intervention. Additional preventive measures should be considered to reduce this complication rate.

Entities:  

Mesh:

Year:  2012        PMID: 23250478     DOI: 10.1007/s00417-012-2205-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  35 in total

Review 1.  Remodelling of the human vitreous and vitreoretinal interface--a dynamic process.

Authors:  Theodorus L Ponsioen; Johanna M M Hooymans; Leonoor I Los
Journal:  Prog Retin Eye Res       Date:  2010-07-16       Impact factor: 21.198

2.  Effect of vitrectomy for epiretinal membrane on visual function and vision-related quality of life.

Authors:  Fumiki Okamoto; Yoshifumi Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Am J Ophthalmol       Date:  2009-02-06       Impact factor: 5.258

3.  Floaters and the quality of life.

Authors:  Jerry Sebag
Journal:  Am J Ophthalmol       Date:  2011-07       Impact factor: 5.258

4.  Surgery for floaters.

Authors:  Marco Mura; Leonore A Engelbrecht; Marc D de Smet; Thekla G Papadaki; Tom J van den Berg; H Stevie Tan
Journal:  Ophthalmology       Date:  2011-09       Impact factor: 12.079

5.  Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters.

Authors:  Y M Delaney; A Oyinloye; L Benjamin
Journal:  Eye (Lond)       Date:  2002-01       Impact factor: 3.775

6.  Age-related changes in human vitreous structure.

Authors:  J Sebag
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

7.  [Pars plana vitrectomy for idiopathic vitreous floaters].

Authors:  M Roth; P Trittibach; F Koerner; G Sarra
Journal:  Klin Monbl Augenheilkd       Date:  2005-09       Impact factor: 0.700

8.  Nuclear sclerotic cataract after vitrectomy in patients younger than 50 years of age.

Authors:  N S Melberg; M A Thomas
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

9.  Enhanced internal search for iatrogenic retinal breaks in 20-gauge macular surgery.

Authors:  H Stevie Tan; Sarit Y Lesnik Oberstein; Marco Mura; Marc D de Smet
Journal:  Br J Ophthalmol       Date:  2010-05-21       Impact factor: 4.638

Review 10.  Diabetic vitrectomy: the influence of lens status upon surgical outcomes.

Authors:  Pawan Bhatnagar; William M Schiff; Gaetano R Barile
Journal:  Curr Opin Ophthalmol       Date:  2008-05       Impact factor: 3.761

View more
  22 in total

1.  Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.

Authors:  Justin H Nguyen; Jeannie Nguyen-Cuu; Fei Yu; Kenneth M Yee; Jonathan Mamou; Ronald H Silverman; Jeffrey Ketterling; J Sebag
Journal:  Ophthalmology       Date:  2019-06-22       Impact factor: 12.079

2.  23G pars plana vitrectomy for vitreal floaters: prospective assessment of subjective self-reported visual impairment and surgery-related risks during the course of treatment.

Authors:  Ursula Hahn; Frank Krummenauer; Klaus Ludwig
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-30       Impact factor: 3.117

Review 3.  Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters.

Authors:  Jan Kokavec; Zhichao Wu; Justin C Sherwin; Alan Js Ang; Ghee Soon Ang
Journal:  Cochrane Database Syst Rev       Date:  2017-06-01

4.  Mid-term safety and effectiveness of intravitreal dexamethasone implant to treat persistent cystoid macular edema in vitrectomized eyes for bacterial endophthalmitis.

Authors:  Giancarlo Sborgia; Alfredo Niro; Valentina Pastore; Rosa Anna Favale; Alessandra Sborgia; Samuele Gigliola; Gianluigi Giuliani; Maria Oliva Grassi; Marco Coassin; Francesco Aiello; Cristiana Iaculli; Michele Reibaldi; Francesco Boscia; Giovanni Alessio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-07       Impact factor: 3.535

5.  YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.

Authors:  Chirag P Shah; Jeffrey S Heier
Journal:  JAMA Ophthalmol       Date:  2017-09-01       Impact factor: 7.389

6.  Pars plana vitrectomy for vitreous floaters: is there such a thing as minimally invasive vitreoretinal surgery?

Authors:  Christopher R Henry; William E Smiddy; Harry W Flynn
Journal:  Retina       Date:  2014-06       Impact factor: 4.256

Review 7.  Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review.

Authors:  T Ivanova; A Jalil; Y Antoniou; P N Bishop; J L Vallejo-Garcia; N Patton
Journal:  Eye (Lond)       Date:  2016-03-04       Impact factor: 3.775

Review 8.  Immunologic Rejection of Transplanted Retinal Pigmented Epithelium: Mechanisms and Strategies for Prevention.

Authors:  Carson C Petrash; Alan G Palestine; M Valeria Canto-Soler
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

9.  Systemic and vitreous biomarkers - new insights in diabetic retinopathy.

Authors:  Bernardete Pessoa; João Heitor; Constança Coelho; Magdalena Leander; Pedro Menéres; João Figueira; Angelina Meireles; Melo Beirão
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-24       Impact factor: 3.535

10.  Evaluation of secondary surgery to enlarge the peeling of the internal limiting membrane following the failed surgery of idiopathic macular holes.

Authors:  Xin Che; Fanglin He; Linna Lu; Dongqing Zhu; Xiaofang Xu; Xin Song; Xianqun Fan; Zhiliang Wang
Journal:  Exp Ther Med       Date:  2014-01-07       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.